7:30 AM - 8:10 AM | Location at UW Medicine to be announced!

Registration will open for members at the UW Medicine South Lake Union Campus in Seattle. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more.

8:05 AM - 8:15 AM | Carlos A. Pellegrini, MD, Chief Medical Officer, UW Medicine; with an introduction from J. Michael Moffat, Chairman, Cavendish Global

UW Medicine’s Chief Medical Officer, Carlos A. Pellegrini, MD, will open the second day of the Seattle Forum on the South Lake Union campus of UW Medicine. Dr. Pellegrini will be introduced by Cavendish Global Chairman, J. Michael Moffat.

8:15 AM - 8:45 AM | Christopher J. L. Murray, MD, DPhil, Professor, IHME; Director and Chair, Department of Health Metrics Sciences

Christopher J.L. Murray, MD, DPhil, is the Director of the Institute for Health Metrics and Evaluation (IHME) and Professor of Global Health at the University of Washington. A physician and health economist, Dr. Murray is widely regarded as one of the founders of modern population health measurement, and his work has helped shape public policy in countries around the world.

Dr. Murray created the concept of the Global Burden of Disease with Dr. Alan Lopez while working as a professor at the Harvard School of Public Health. Dr. Murray led the coordination of the Global Burden of Disease Study 2010, the most comprehensive assessment to date of levels and trends in health worldwide. He served as the Executive Director of the World Health Organization’s Evidence and Information for Policy Cluster, where he pioneered the groundbreaking World Health Report 2000, in collaboration with Dr. Julio Frenk. Dr. Murray played a key role in the creation of the 1993 World Development Report, considered a touchstone for all subsequent attempts to study the effects of health policy and health investment on health outcomes. He returned to Harvard to help launch the Harvard Initiative for Global Health (now the Harvard Institute for Global Health) as its first director.

Dr. Murray’s work has been cited more than 50,000 times by other researchers in published articles. He holds Bachelor of Arts and Science degrees from Harvard University, a DPhil from Oxford University, and a medical degree from Harvard Medical School.

Dr. Murray and Dr. Frenk founded IHME in 2007. By measuring health, tracking program performance, finding ways to maximize health system impact, and developing innovative measurement systems, IHME provides a foundation for informed decision-making that ultimately will lead to better health globally.

8:45 AM - 9:45 AM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs.

9:45 AM - 10:30 AM | Orin Smith Conference Center at UW Medicine

Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations.

Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.

10:30 AM - 11:00 AM | Featuring Sarah Lucas, Co-Founder & CEO, Beyond Type 1, interviewed by Rachel Butler, Executive Director, Cavendish Impact Foundation

Sarah is the CEO of Beyond Type 1, a nonprofit organization leveraging the power of social media and technology, changing what it means to live with a chronic condition.  In just three years, her team has built a powerhouse global brand with the largest digital audience of any diabetes organization in the world. The result is improved health outcomes for millions of people, new opportunities to partner with iconic brands and the ability to consolidate other non-profits for greater impact.  Sarah will discuss how venture capital, the tech and design worlds and traditional non-profit practices influenced the building of this new brand of philanthropy.

11:00 AM - 11:30 AM | Featuring Brian Slizgi, Director, Pharma R&D Advisory, PwC

Brian Slizgi, PwC Director of Pharma R&D Advisory will discuss the latest trends around the application of blockchain technology in biohealth, including opportunities and challenges for early-stage companies.

11:30 AM - 12:00 PM | Featuring James Lumberg, Co-Founder & EVP, Envestnet, together with James Patrick, Co-Founder & EVP, Envestnet, and Chairman of the Cavendish Impact Foundation

Details to be announced!

12:00 PM - 1:15 PM | Orin Smith Conference Center and surrounding lounge areas

Break bread with fellow Cavendish members and leaders from the University of Washington over a casual buffet lunch at UW Medicine. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine.

1:15 PM - 1:45 PM | Moderated by Peter McCrea, President, Cavendish Impact Foundation, together with Timothy Freundlich, President, ImpactAssets

In this fourth installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Peter McCrea joins philanthropic partner, ImpactAssets' President, Timothy Freundlich, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators.

1:45 PM - 2:15 PM | Charles (Chuck) E. Murry, MD, PhD, Director, UW Institute for Stem Cell and Regenerative Medicine; Co-Director, UW Center for Cardiovascular Biology; Co-Director, UW Medicine Heart Regeneration Program

Dr. Murry’s research focuses on stem cell biology, with an emphasis on understanding differentiation of the human cardiovascular system and using these cells to study diseases and to regenerate damaged tissues.  His group is a world leader in heart regeneration and is working toward a clinical trial using cardiomyocyte therapy.

2:15 PM - 3:15 PM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs.

(Image: David Huizenga, CEO, Moterum Technologies)

3:15 PM - 4:00 PM | Orin Smith Conference Center at UW Medicine

Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations.

Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.

4:00 PM - 4:30 PM | Featuring Ramona Hicks, PhD, Science and Technology Director, One Mind

At One Mind, Dr. Hicks works to facilitate the exchange of scientific knowledge across neuropsychiatric disorders, international borders, and academic and commercial entities to accelerate the development of diagnostic tools, biomarkers, and effective treatments. Projects include developing the One Mind Portal into a user-friendly and useful tool for research collaboration, especially among large, multi-center studies, implementing an evidence-informed screening and management tool for concussion in emergency departments (Screen-Inform-Prevent), and exploring opportunities for a public-private psychosis research initiative.

4:30 PM - 5:00 PM | Heather Mefford, MD, PhD, Director, Mefford Laboratory, Division of Genetic Medicine, University of Washington

Dr. Mefford is a physician at Seattle Children’s Hospital and an Associate Professor of Pediatrics at the University of Washington. She directs a research laboratory in the Division of Genetic Medicine that is devoted to gene discovery in pediatric disorders, with a focus on severe pediatric epilepsies. The Mefford Lab has identified numerous new epilepsy genes, which are now tested in the clinical setting. She has also been a key member of international consortium efforts for epilepsy gene discovery. Her clinical interests parallel her research interests and include seeing patients with suspected genetic disorders, pediatric epilepsies and neurocognitive defects of unknown causes.

5:00 PM - 8:00 PM | UW Medicine Orin Smith Lounge and surrounding areas

General Session programming will close with an immediate opening of the Evening Cocktail Reception. The UW Medicine reception will feature exclusive tours of research laboratories, along with interactive technology showcased by the Institute for Health Metrics and Evaluation!

Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2019 San Francisco Forum in February. Be sure to check in with the Cavendish team on unique local dinner destinations to continue the conversations, post-Forum!